临床试验的分散化:机遇,风险和发展路径
Chiara Crepaldi1, Alessandro Venturi2, Luisa Brogonzoli1
1Fondazione The Bridge.
Studies in health technology and informatics
|June 30, 2023
概括
COVID-19大流行刺激了临床试验设计的创新,强调了分散和数字化的方法. 这项研究为意大利的去中心化临床试验提供了可行性指南,具有更广泛的欧洲相关性.
科学领域:
- 临床研究 临床研究
- 卫生政策 卫生政策
- 数字健康数字健康
背景情况:
- 疫情加快了更新临床试验研究流程的需要.
- 越来越需要探索设计和组织临床试验的新方法.
研究的目的:
- 分析临床试验中去中心化和数字化的影响.
- 为意大利的分散的临床试验协议提出可行性准则.
主要方法:
- 文学分析. 文学分析.
- 多学科工作组合作 (临床医生,患者代表,学者,研究人员,卫生政策和数字健康专家).
- 关于分散和数字化试验的积极方面,关键问题和风险的对抗.
主要成果:
- 确定了与分散和数字化临床试验相关的各种利益相关者的积极方面,关键问题和风险.
- 专门为意大利制定了分散的临床试验协议的可行性准则.
结论:
- 分散和数字化的临床试验为研究过程更新提供了机会.
- 拟议的指导方针和反思对于意大利和可能其他寻求实施分散试验模型的欧洲国家来说都很重要.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Drug Administration and Therapy Phases: Overview
557
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
557
Drug Control Governance: Regulatory Bodies and Their Impact
190
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
190


